CHF126.30
0.79% yesterday
SIX Swiss Exchange, Jul 21, 05:30 pm CET
ISIN
CH1335392721
Symbol
GALD
Index
Sector
Industry

Galderma Stock price

CHF126.30
+15.00 13.48% 1M
+17.00 15.55% 6M
+25.66 25.50% YTD
+54.83 76.72% 1Y
+73.30 138.30% 3Y
+73.30 138.30% 5Y
+73.30 138.30% 10Y
+73.30 138.30% 20Y
SIX Swiss Exchange, Closing price Mon, Jul 21 2025
-1.00 0.79%
ISIN
CH1335392721
Symbol
GALD
Index
Sector
Industry

Key metrics

Basic
Market capitalization
CHF30.2b
Enterprise Value
CHF32.0b
Net debt
CHF1.8b
Cash
CHF364.7m
Shares outstanding
237.4m
Valuation (TTM | estimate)
P/E
163.2 | 57.4
P/S
8.5 | 7.5
EV/Sales
9.0 | 8.0
EV/FCF
187.3
P/B
4.8
Dividends
DPS
CHF0.15
Yield 1Y | 5Y
0.1% | 0.0%
Growth 1Y | 5Y
100.0% | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
1 Year
Financials (TTM | estimate)
Revenue
CHF3.5b | CHF4.0b
EBITDA
CHF772.5m | CHF914.9m
EBIT
CHF538.7m | CHF787.2m
Net Income
CHF184.3m | CHF526.5m
Free Cash Flow
CHF170.0m
Growth (TTM | estimate)
Revenue
- | 12.3%
EBITDA
- | 17.8%
EBIT
- | 45.3%
Net Income
- | 184.0%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
69.5%
EBITDA
21.8% | 22.9%
EBIT
15.2%
Net
5.2% | 13.2%
Free Cash Flow
4.8%
Financial Health
Equity Ratio
61.7%
Return on Equity
3.0%
ROCE
6.1%
ROIC
4.5%
Debt/Equity
0.4
More
EPS
CHF0.8
FCF per Share
CHF0.7
Short interest
-
Employees
-
Rev per Employee
-
Show more

Is Galderma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,010 stocks worldwide.

Galderma Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Galderma forecast:

14x Buy
78%
4x Hold
22%

Analyst Opinions

18 Analysts have issued a Galderma forecast:

Buy
78%
Hold
22%

Financial data from Galderma

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
3,543 3,543
-
100%
- Direct Costs 1,081 1,081
-
31%
2,462 2,462
-
69%
- Selling and Administrative Expenses 1,532 1,532
-
43%
- Research and Development Expense 207 207
-
6%
772 772
-
22%
- Depreciation and Amortization 234 234
-
7%
EBIT (Operating Income) EBIT 539 539
-
15%
Net Profit 184 184
-
5%

In millions CHF.

Don't miss a Thing! We will send you all news about Galderma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Head office Switzerland
CEO Flemming Ørnskov
Website www.galderma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today